Loading
Baronsmead Venture Trust PLC Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest was filed 14 May 2026.
Baronsmead Venture Trust PLC: what insiders have been doing
Baronsmead Venture Trust PLC belongs to the Finance & Banking sector. Filings by its managers are published through RNS (LSE). Over the twelve months to 18 October 2026, 7 filings were filed, from 5 insiders.
Every open-market trade in the period is a purchase: 5 purchases worth €65k, from 5 insiders, and not a single sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 5 board members among the declarants. One trade stands out by size: a purchase of €29k from Michael Probin, disclosed on 14 May 2026, or 0.014% of market capitalisation.
For context, the typical company on the same exchange (median of 832 companies) published 6 filings over the same period, against 7 filings here. Our records for Baronsmead Venture Trust PLC go back to 2024, with 12 purchases and no sales on the open market in total.
Within a 30-day window, 1 purchase overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The clock since the last published purchase (14 May 2026) now reads 157 days. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, UK MAR gives managers three business days to notify a trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at First Guaranty Bancshares, Inc. and BCB Bancorp Inc. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Insider Decl.
18
Thresholds
n/a
Buy Volume
€152,737
12 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleMichael Probin5 buys
Fiona Miller Smith2 buys
David Logan Melvin1 buy
David Melvin1 buy
Mandeep Singh1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended September 2025 · cache
£0.43
Analyst consensus
Income statement
Revenue£3.9M
Net income£3.2M82.0% margin
Valuation
PER (trailing)43.4x
P/Book95.0x
Beta0.03
Balance sheet & cash
Market cap£192.2M
Free Cash Flow-£2.4M
Profitability & ownership
ROE-0.5%
ROA-0.3%
% insiders0.1%
% institutions0.0%
Last declaration on 18 September 2026
Declarations18 total
7,339 shares@ £0.43590.0017% mcap13.4% of flowLondon Stock Exchange (XLON)ISIN GB0002631934FCA-NSM:d4b912a5-6152-43c0-b6bc-705e8cbf9c6b
50,555 shares@ £0.49450.014% mcap40.5% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:9569265
Canonical exit: 12 Aug 2026 (T+90)
7,248 shares@ £0.4310.0018% mcap12.9% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:6c9f2e34-e5e1-4977-869f-e89106ff93a5
10,700 shares@ £0.46730.0028% mcap32.5% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:c59a0fc2-73b1-47f8-9a13-7905e69ae54c
Canonical exit: 1 Jul 2026 (T+90)
10,756 shares@ £0.46490.0028% mcap100.0% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:e7624c37-ee84-48f8-99f1-aa83cb09841d
Canonical exit: 1 Jul 2026 (T+90)
18,084 shares@ £0.553100.0% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:f5abd304-784c-4c0d-a330-7ebb402b0ba0
Canonical exit: 20 May 2026 (T+90)
22,498 shares@ £0.533419.2% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:02487ff9-a2ff-4acb-984f-ce960015aa36
Canonical exit: 18 Feb 2026 (T+90)
4,681 shares@ £0.48369.4% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:5817798
18,593 shares@ £0.537842.1% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:5702084
Canonical exit: 16 Sept 2025 (T+90)
37,702 shares@ £0.5305100.0% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:5628433
Canonical exit: 2 Jul 2025 (T+90)
3,487 shares@ £0.48857.3% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:5593011
22,673 shares@ £0.529320.5% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:5546776
Canonical exit: 21 May 2025 (T+90)
9,447 shares@ £0.529334.3% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:5546773
Canonical exit: 21 May 2025 (T+90)
2,634 shares@ £0.54856.2% of flowLondon Stock Exchange (XLON)ISIN GB0030028103RNS:5366144
3,741 shares@ £0.5548.7% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:5109218
8,717 shares@ £0.573633.2% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:5069298
Canonical exit: 15 May 2024 (T+90)
17,080 shares@ £0.5855100.0% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:5049976
Canonical exit: 25 Apr 2024 (T+90)
20,549 shares@ £0.58419.8% of flowLondon Stock Exchange (XLON)ISIN GB0002631934RNS:5049973
Canonical exit: 25 Apr 2024 (T+90)
18 of 18 declarations
About Baronsmead Venture Trust PLC
Baronsmead Venture Trust PLC is a listed venture capital trust (VCT) focused on financing and supporting early-stage and growth-oriented UK businesses. The company is quoted on the London Stock Exchange (FTSE 100/250/AIM) in the United Kingdom and sits within the closed-ended investment fund universe. It was incorporated on 29 January 1998 as Baronsmead VCT 2 PLC and adopted its current name in 2016. Its registered office is in London at 5 New Street Square, United Kingdom, EC4A 3TW.
From an investment standpoint, Baronsmead Venture Trust is designed to provide shareholders with long-term attractive returns, combining capital growth and dividend income in a tax-efficient VCT structure. The portfolio is managed by Gresham House Asset Management, and the trust invests alongside entrepreneurial UK companies across market cycles. Its mandate spans both unquoted investments and AIM-listed companies, giving it a hybrid portfolio construction that blends private and public growth exposure.
Read moreShow less
The trust’s competitive edge lies in its access to a specialist manager, a broad sourcing network, and active support capabilities. Gresham House emphasizes that the Baronsmead VCTs back pioneering businesses that it believes can sit at the heart of the future UK economy. The portfolio is broad and diversified, with exposure across sectors such as technology, healthcare and hospitality, alongside other areas of UK innovation and smaller-company growth. This diversification is important in a VCT context, where deal access, valuation discipline and post-investment support often differentiate long-term outcomes.
Geographically, the trust is primarily UK-focused, which is consistent with VCT rules and tax efficiency requirements. Its strategy is centered on supporting domestic growth companies, often in niche markets with structural expansion potential, while preserving the flexibility to hold, support and exit investments over multi-year horizons. The backing of Gresham House also provides operational expertise, board-level input on selected holdings, and access to a wider alternative-asset network.
Recent corporate activity has been active. Baronsmead Venture Trust published its annual report for the year ended 30 September 2025, and in 2026 it has continued to issue RNS updates, including Director/PDMR Shareholding notifications. It also launched and updated a fundraising offer for the Baronsmead VCTs, including over-allotment capacity, underlining continued capital deployment and portfolio replenishment. For French, Belgian and Swiss investors, Baronsmead Venture Trust offers a specialist listed vehicle for accessing UK entrepreneurial growth, with a disciplined, diversified and manager-led approach on the London Stock Exchange (FTSE 100/250/AIM) in the United Kingdom.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
